| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |